US Diagnostics Business Drives up Meridian Bioscience Q1 Revenues 13 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Meridian Bioscience today said that revenues in its fiscal first quarter rose 13 percent year over year, led by its US Diagnostics unit.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.